This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Lin Chen, PhD
Manager, Process Development at Corden Pharma Colorado
Speaker

Profile

Lin Chen is the Manager, Process Development, at Corden Pharma Colorado. He obtained his PhD with Professor George Barany from University of Minnesota at Twin Cities. After working on high throughput peptide synthesis for several years at Axcell Biosciences, a Cytogen subsidiary on the east coast, he joined Roche Colorado Corporation in Boulder to begin his API process development career. He was a Distinguished Scientist when CordenPharma acquired the Roche facility in Boulder. Dr. Lin Chen has more than 20 years of GMP process development experience, especially in the field of synthetic peptides.

Agenda Sessions

  • Green SPPS – An Effort to Minimize the Environmental Impact Related to the SPPS Process

    12:20pm